Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2016	Apr. 04, 2015
Cash flows from operating activities:
Net income	$ 2,663	$ 1,824
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	72,256	66,398
Loss on disposal of property, plant, equipment and other assets	698	47
Gain on insurance proceeds from insurance settlements	0	(341)
Deferred taxes	(3,705)	503
Increase/(decrease) in long-term pension liability	(1,146)	261
Stock-based compensation expense	2,440	1,282
Deferred loan cost amortization	2,794	2,409
Equity in net (income)/loss of unconsolidated subsidiaries	(5,643)	1,808
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	7,118	12,269
Income taxes refundable/payable	400	(1,857)
Inventories and prepaid expenses	(21,206)	(26,511)
Accounts payable and accrued expenses	3,336	(19,985)
Other	(14,962)	21,133
Net cash provided by operating activities	45,043	59,240
Cash flows from investing activities:
Capital expenditures	(53,375)	(50,838)
Acquisitions, net of cash acquired	(8,511)	0
Gross proceeds from disposal of property, plant and equipment and other assets	1,424	534
Proceeds from insurance settlement	1,181	341
Payments related to routes and other intangibles	0	(753)
Net cash used by investing activities	(59,281)	(50,716)
Cash flows from financing activities:
Proceeds from long-term debt	8,760	5,943
Payments on long-term debt	(16,207)	(13,602)
Borrowings from revolving credit facility	33,000	27,428
Payments on revolving credit facility	(21,000)	(37,943)
Net cash overdraft financing	0	31,162
Issuance of common stock	45	81
Repurchase of treasury stock	(5,000)	0
Minimum withholding taxes paid on stock awards	(1,788)	(4,469)
Excess tax benefits from stock-based compensation	(446)	(35)
Distributions to noncontrolling interests	0	(38)
Net cash provided/(used) by financing activities	(2,636)	8,527
Effect of exchange rate changes on cash	7,316	(13,704)
Net increase/(decrease) in cash and cash equivalents	(9,558)	3,347
Cash and cash equivalents at beginning of period	156,884	108,784
Cash and cash equivalents at end of period	147,326	112,131
Supplemental disclosure of cash flow information:
Accrued capital expenditures	(6,595)	2,164
Cash paid during the period for:
Interest, net of capitalized interest	20,597	26,118
Income taxes, net of refunds	5,114	5,149
Debt issued for assets	10	0
Contribution of assets to unconsolidated subsidiary	$ 2,674	$ 0